Cargando…
Psoriatic arthritis: recent progress in pathophysiology and drug development
Psoriatic arthritis (PsA) is the second most common inflammatory arthropathy, after rheumatoid arthritis diagnosis, in early arthritis clinics. Most patients have established psoriasis, often for years, prior to the onset of joint pain and swelling; in addition, associated features of nail disease,...
Autor principal: | Veale, Douglas James |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061722/ https://www.ncbi.nlm.nih.gov/pubmed/24611179 http://dx.doi.org/10.1186/ar4414 |
Ejemplares similares
-
Targeted Therapies in Psoriatic Arthritis—An Update
por: Sundanum, Sonia, et al.
Publicado: (2023) -
What makes psoriatic and rheumatoid arthritis so different?
por: Veale, Douglas James, et al.
Publicado: (2015) -
Enthesitis in psoriatic arthritis (Part 1): pathophysiology
por: Araujo, Elizabeth G, et al.
Publicado: (2020) -
Autoimmunity in psoriatic arthritis: pathophysiological and clinical aspects
por: EMMUNGİL, Hakan, et al.
Publicado: (2021) -
Recent advances in understanding and managing psoriatic arthritis
por: Gladman, Dafna D.
Publicado: (2016)